Overview
Rasmus Sorensen-Dahl practices practicing medicine in Roskilde, Denmark.
His clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rasmus B. Sorensen-Dahl
Is Rasmus B. Sorensen-Dahl a top-rated expert for Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Rasmus B. Sorensen-Dahl is classified as an Experienced expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rasmus B. Sorensen-Dahl participate in research or clinical trials?
Yes. Rasmus B. Sorensen-Dahl has published 8 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Rasmus B. Sorensen-Dahl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Classical Hodgkin LymphomaMr. Sorensen-Dahl isExperienced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaMr. Sorensen-Dahl isExperienced. Learn about Hodgkin Lymphoma.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)